Mesa Laboratories
MLAB
155 hedge funds and large institutions have $534M invested in Mesa Laboratories in 2024 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 55 increasing their positions, 48 reducing their positions, and 26 closing their positions.
15% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 48
0% less capital invested
Capital invested by funds: $535M → $534M (-$513K)
2% less funds holding
Funds holding: 158 → 155 (-3)
4.44% less ownership
Funds ownership: 94.73% → 90.29% (-4.4%)
12% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 26
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Boone Capital Management
Atlanta,
Georgia
|
+$6.98M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$3.07M |
| 3 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$2.76M |
| 4 |
KTA
Keeley-Teton Advisors
Chicago,
Illinois
|
+$2.39M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.09M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$27.3M |
| 2 |
Goldman Sachs
New York
|
-$5.86M |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$4.77M |
| 4 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
-$3.25M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$1.99M |
MLAB Hedge Fund Activity: Q1 2024 in Review
155 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Mesa Laboratories (MLAB) for Q1 2024, worth a combined $534M — down 0.1% from $535M a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of MLAB and 23 opened new positions — a net loss of 3 holders — while 48 trimmed existing stakes and 55 added.
The largest buyer was Boone Capital Management, adding an estimated $6.98M. The largest seller was Morgan Stanley, cutting an estimated $27.3M.
- 155 institutional investors held Mesa Laboratories (MLAB) as of Q1 2024, down from 158 in Q4 2023.
- Funds reported $534M of Mesa Laboratories stock for Q1 2024, down 0.1% quarter-over-quarter.
- 23 funds opened new Mesa Laboratories positions in Q1 2024 and 26 closed out, a net change of -3 holders.
- The largest Mesa Laboratories buyer in Q1 2024 was Boone Capital Management, an estimated $6.98M added.
- The largest Mesa Laboratories seller in Q1 2024 was Morgan Stanley, an estimated $27.3M sold.
Based on aggregated 13F filings for Q1 2024.